Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Takeda Pharmaceutical ADR | TAK | 26. avr 2024 | 13.03 | -0.31 |
TAL Education Group ADR | TAL | 26. avr 2024 | 13.41 | +0.45 |
Talis Biomedical | TLIS | 26. avr 2024 | 9.14 | +1.56 |
Talkspace | TALK | 26. avr 2024 | 3.12 | +1.30 |
Talos Energy | TALO | 26. avr 2024 | 13.94 | +1.16 |
Talphera | TLPH | 26. avr 2024 | 1.05 | 0.00 |
Tandem Diabetes Care | TNDM | 26. avr 2024 | 35.24 | -0.90 |
Tanger | SKT | 26. avr 2024 | 28.88 | +0.73 |
Tango Therapeutics | TNGX | 26. avr 2024 | 7.44 | +1.50 |
Tantech | TANH | 26. avr 2024 | 0.56 | 0.00 |
Taoping | TAOP | 26. avr 2024 | 0.98 | -5.77 |
Tapestry | TPR | 26. avr 2024 | 40.05 | +1.68 |
Targa Resources | TRGP | 26. avr 2024 | 116.86 | -0.70 |
Target | TGT | 26. avr 2024 | 164.74 | +0.18 |
Target Global Acquisition I A | TGAA | 26. avr 2024 | 11.20 | 0.00 |
Target Global Acquisition I Unit | TGAAU | 26. avr 2024 | 11.13 | 0.00 |
Target Hospitality | TH | 26. avr 2024 | 11.12 | +0.36 |
Taro Pharmaceutical Industries | TARO | 26. avr 2024 | 42.40 | -0.19 |
Tarsus Pharmaceuticals | TARS | 26. avr 2024 | 32.04 | -0.53 |
Taseko Mines | TGB | 26. avr 2024 | 2.60 | +5.26 |
TaskUs A | TASK | 26. avr 2024 | 11.59 | +2.57 |
TAT Technologies | TATT | 26. avr 2024 | 11.89 | +2.50 |
Taylor Devices | TAYD | 26. avr 2024 | 51.83 | -1.13 |
Taylor Morrison Home | TMHC | 26. avr 2024 | 57.56 | +2.27 |
Taysha Gene Therapies | TSHA | 26. avr 2024 | 2.39 | +3.91 |
TC Bancshares | TCBC | 26. avr 2024 | 13.66 | +0.44 |
TC Biopharm ADR | TCBP | 26. avr 2024 | 1.53 | -2.55 |
TC Energy | TRP | 26. avr 2024 | 36.10 | +0.03 |
TCTM Kids IT Education ADR | TCTM | 26. avr 2024 | 2.11 | 0.00 |
TCW Strategic | TSI | 26. avr 2024 | 4.60 | +0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.